A class of compounds is described which can be used for the treatment of viral infections. Compounds of particular interest are defined by Formula (II) wherein each of R?1, R2, and R3¿ is independently selected from hydrido, halo, and nitro; wherein R8 is selected from haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted arylalkoxy and optionally substituted aryloxyalkyl; wherein Y is selected from fluoroalkyl, and (A); and wherein (R9) is alkylamino; or a pharmaceutically-acceptable salt or tautomer thereof.